Logo image of VERX

VERTEX INC - CLASS A (VERX) Stock Fundamental Analysis

NASDAQ:VERX - US92538J1060 - Common Stock

24.22 USD
+0.35 (+1.47%)
Last: 9/11/2025, 1:20:04 PM
Fundamental Rating

3

Overall VERX gets a fundamental rating of 3 out of 10. We evaluated VERX against 280 industry peers in the Software industry. VERX has a bad profitability rating. Also its financial health evaluation is rather negative. VERX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

VERX had positive earnings in the past year.
In the past year VERX had a positive cash flow from operations.
VERX had negative earnings in each of the past 5 years.
Each year in the past 5 years VERX had a positive operating cash flow.
VERX Yearly Net Income VS EBIT VS OCF VS FCFVERX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

VERX has a Return On Assets of -4.21%. This is comparable to the rest of the industry: VERX outperforms 45.36% of its industry peers.
The Return On Equity of VERX (-20.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.21%
ROE -20.32%
ROIC N/A
ROA(3y)-2.65%
ROA(5y)-4.32%
ROE(3y)-13.31%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
VERX Yearly ROA, ROE, ROICVERX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

VERX has a Gross Margin of 65.00%. This is comparable to the rest of the industry: VERX outperforms 44.64% of its industry peers.
In the last couple of years the Gross Margin of VERX has remained more or less at the same level.
VERX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-0.54%
VERX Yearly Profit, Operating, Gross MarginsVERX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

VERX does not have a ROIC to compare to the WACC, probably because it is not profitable.
VERX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VERX has been increased compared to 5 years ago.
The debt/assets ratio for VERX is higher compared to a year ago.
VERX Yearly Shares OutstandingVERX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VERX Yearly Total Debt VS Total AssetsVERX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

VERX has an Altman-Z score of 2.92. This is not the best score and indicates that VERX is in the grey zone with still only limited risk for bankruptcy at the moment.
VERX has a Altman-Z score (2.92) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.36 is on the high side and indicates that VERX has dependencies on debt financing.
VERX's Debt to Equity ratio of 1.36 is on the low side compared to the rest of the industry. VERX is outperformed by 78.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Altman-Z 2.92
ROIC/WACCN/A
WACC11.14%
VERX Yearly LT Debt VS Equity VS FCFVERX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

VERX has a Current Ratio of 0.99. This is a bad value and indicates that VERX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of VERX (0.99) is worse than 72.86% of its industry peers.
VERX has a Quick Ratio of 0.99. This is a bad value and indicates that VERX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.99, VERX is doing worse than 71.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
VERX Yearly Current Assets VS Current LiabilitesVERX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

VERX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.09%, which is quite good.
Measured over the past years, VERX shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.31% on average per year.
VERX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.01%.
VERX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.71% yearly.
EPS 1Y (TTM)15.09%
EPS 3Y25.31%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.01%
Revenue growth 3Y16.15%
Revenue growth 5Y15.71%
Sales Q2Q%14.56%

3.2 Future

The Earnings Per Share is expected to grow by 20.95% on average over the next years. This is a very strong growth
Based on estimates for the next years, VERX will show a quite strong growth in Revenue. The Revenue will grow by 14.73% on average per year.
EPS Next Y4.44%
EPS Next 2Y13.41%
EPS Next 3Y20.3%
EPS Next 5Y20.95%
Revenue Next Year13.2%
Revenue Next 2Y13.2%
Revenue Next 3Y14.03%
Revenue Next 5Y14.73%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VERX Yearly Revenue VS EstimatesVERX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
VERX Yearly EPS VS EstimatesVERX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.70, the valuation of VERX can be described as expensive.
VERX's Price/Earnings ratio is a bit cheaper when compared to the industry. VERX is cheaper than 61.07% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. VERX is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 30.87, VERX can be considered very expensive at the moment.
62.86% of the companies in the same industry are more expensive than VERX, based on the Price/Forward Earnings ratio.
VERX's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.54.
Industry RankSector Rank
PE 39.7
Fwd PE 30.87
VERX Price Earnings VS Forward Price EarningsVERX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

63.93% of the companies in the same industry are more expensive than VERX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.06
VERX Per share dataVERX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VERX does not grow enough to justify the current Price/Earnings ratio.
VERX's earnings are expected to grow with 20.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.95
PEG (5Y)N/A
EPS Next 2Y13.41%
EPS Next 3Y20.3%

0

5. Dividend

5.1 Amount

VERX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VERTEX INC - CLASS A

NASDAQ:VERX (9/11/2025, 1:20:04 PM)

24.22

+0.35 (+1.47%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners112.05%
Inst Owner Change16.43%
Ins Owners6.4%
Ins Owner Change23.73%
Market Cap3.86B
Analysts77.27
Price Target38.48 (58.88%)
Short Float %9.84%
Short Ratio4.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.43%
Min EPS beat(2)3.56%
Max EPS beat(2)9.3%
EPS beat(4)4
Avg EPS beat(4)8.81%
Min EPS beat(4)3.56%
Max EPS beat(4)15.34%
EPS beat(8)8
Avg EPS beat(8)10.53%
EPS beat(12)11
Avg EPS beat(12)12.06%
EPS beat(16)15
Avg EPS beat(16)17.85%
Revenue beat(2)0
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)0.84%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.16%
PT rev (1m)-20.33%
PT rev (3m)-18.65%
EPS NQ rev (1m)-6.2%
EPS NQ rev (3m)-15.43%
EPS NY rev (1m)-1.36%
EPS NY rev (3m)-1%
Revenue NQ rev (1m)-2.11%
Revenue NQ rev (3m)-1.54%
Revenue NY rev (1m)-1.37%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE 39.7
Fwd PE 30.87
P/S 5.44
P/FCF N/A
P/OCF 26.95
P/B 15.57
P/tB N/A
EV/EBITDA 48.06
EPS(TTM)0.61
EY2.52%
EPS(NY)0.78
Fwd EY3.24%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.9
OCFY3.71%
SpS4.46
BVpS1.56
TBVpS-1.16
PEG (NY)8.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.21%
ROE -20.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65%
FCFM N/A
ROA(3y)-2.65%
ROA(5y)-4.32%
ROE(3y)-13.31%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-0.54%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Debt/EBITDA 4.19
Cap/Depr 189.92%
Cap/Sales 23.28%
Interest Coverage N/A
Cash Conversion 178.54%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 2.92
F-Score4
WACC11.14%
ROIC/WACCN/A
Cap/Depr(3y)135.67%
Cap/Depr(5y)121.89%
Cap/Sales(3y)16.89%
Cap/Sales(5y)14.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.09%
EPS 3Y25.31%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y4.44%
EPS Next 2Y13.41%
EPS Next 3Y20.3%
EPS Next 5Y20.95%
Revenue 1Y (TTM)15.01%
Revenue growth 3Y16.15%
Revenue growth 5Y15.71%
Sales Q2Q%14.56%
Revenue Next Year13.2%
Revenue Next 2Y13.2%
Revenue Next 3Y14.03%
Revenue Next 5Y14.73%
EBIT growth 1Y-557.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.41%
EBIT Next 3Y28.57%
EBIT Next 5Y26.7%
FCF growth 1Y-140.27%
FCF growth 3Y-49.75%
FCF growth 5Y-35.88%
OCF growth 1Y112.79%
OCF growth 3Y21.47%
OCF growth 5Y12.25%